Malaffi will house different types of patient medical information, collated from different Abu Dhabi healthcare providers, including allergies, diagnoses, medications, laboratory and radiology reports, clinical notes, and other. Laboratory test results inform the majority of medical decisions and are among the main types of information centralised in Malaffi. Access to the longitudinal records of patients’ laboratory results, collated from the different on-site and referral laboratories, presents vital information for physicians and will undoubtedly enhance reliable and timely diagnosis for patients in Abu Dhabi.

Mohamed Al Hameli, Undersecretary of Department of Health, commented: “At the Department of Health, we strive to remain a leader in patient experience and to continue enhancing healthcare quality standards while ensuring the sector’s long-term sustainability. We are proud to welcome
VPS Healthcare Group and the first two network of clinical laboratories to the Malaffi network. We are confident that the system will be a central platform for facilitating information exchange among health facilities in the Emirate, and will continue elevating the quality and efficiency of healthcare delivery in the Emirate.”

“We are glad to welcome the new Malaffi participants – VPS Healthcare, National Reference Laboratory and MENALabs to the Malaffi network. The participation of these providers will increase the value of information available to healthcare professionals through Malaffi, affording improved patient outcomes,” said Atif Al Braiki, the Chief Executive Officer of Abu Dhabi Health Data Services, the operator of Malaffi.

The Next Wave of Healthcare Providers Join Malaffi

“In addition to centrally storing patients’ clinical information and laboratory tests results, another great benefit of Malaffi is enabling the enhanced practice of precision medicine. At MENALabs we specialise in genetic tests, which are a very important prerequisite for precision medicine. This common goal brings us together and is why we are especially honoured to be among the first laboratories in Abu Dhabi to join Malaffi,” said Zerela Henry, Chief Executive Officer of MENALabs.

“We believe that the Malaffi platform will enable all healthcare providers to manage their data more efficiently,” said Dr. Shamsheer Vayalil, Chairman and Managing Director of VPS Healthcare that operates Burjeel, Medeor, LLH and Lifecare hospitals and clinics in the UAE.

“These data sets will also be of great value for stratifying populations to achieve public health priorities and recommendations, while at the same time empowering patients and ensuring they are equal stakeholders for their health and well-being,” he added.

“This will also allow us to produce actionable insights to improve patient outcomes. As healthcare delivery in the UAE evolves, we need data for everything from managing increasing medical costs to providing personalised medicines for complex conditions.”

“NRL is proud to be one of the first laboratories to join Malaffi. We truly believe Malaffi will help elevate patient experiences and support the making of timely clinical decisions by reducing unnecessary duplication of laboratory tests. As a network of ten laboratories across the UAE and the biggest laboratory network in the Middle East, accredited by the College of American Pathologists (CAP), NRL has been investing in advanced IT systems. Thanks to this we are in a great position to be among the first providers to implement Malaffi for our Abu Dhabi-based laboratories,” says Abdul Hamid Oubeisi, Chief Executive Officer of NRL.

As provided in the DOH Policy on ADHIE, the DOH seeks to ensure that all licensed Healthcare Facilities in the Emirate of Abu Dhabi participate in Malaffi. All Abu Dhabi healthcare facilities are expected to begin utilising Malaffi by the end of 2019.

All healthcare facilities need to verify their scheduled deadlines in the full launch schedule posted on Malaffi’s website - .

For more information, providers can contact the Malaffi Onboarding Team at